PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Dantrolene sodium (Systemic)
Presentation Product Chemical substance Chapter Items dispensed
Dantrolene 25mg capsules
1002020J0AAAAAA
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases 9,065
Dantrolene 100mg capsules
1002020J0AAABAB
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases 1,407
Dantrolene 25mg/5ml oral suspension
1002020J0AABHBH
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases 93
Dantrolene 25mg/5ml oral solution
1002020J0AAARAR
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases 39
Dantrolene 100mg/5ml oral suspension
1002020J0AABQBQ
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases 37
Dantrolene 10mg/5ml oral suspension
1002020J0AABRBR
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases 8
Dantrolene 1.25mg/5ml oral liquid
1002020J0AABKBK
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases 1
Dantrolene 12.5mg/5ml oral liquid
1002020J0AAAUAU
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases 1
Dantrolene 100mg/5ml oral solution
1002020J0AABIBI
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 10mg/5ml oral solution
1002020J0AAAXAX
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 15mg/5ml oral liquid
1002020J0AABCBC
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 16.67mg/5ml oral liquid
1002020J0AAAWAW
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 2.5mg/5ml oral liquid
1002020J0AAAQAQ
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 20mg/5ml oral liquid
1002020J0AAATAT
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 2mg/5ml oral liquid
1002020J0AABEBE
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 4.5mg/5ml oral liquid
1002020J0AABDBD
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 50mg/5ml oral liquid
1002020J0AAAVAV
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 5mg/5ml oral liquid
1002020J0AAAZAZ
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 6.5mg/5ml oral liquid
1002020J0AABFBF
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 6mg/5ml oral liquid
1002020J0AAAYAY
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 75mg/5ml oral liquid
1002020J0AABMBM
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 7mg/5ml oral liquid
1002020J0AAASAS
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 833micrograms/5ml oral liquid
1002020J0AABNBN
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 8mg/5ml oral liquid
1002020J0AABGBG
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available
Dantrolene 90mg/5ml oral liquid
1002020J0AABJBJ
Dantrolene sodium (Systemic) Dantrolene sodium Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.